Recursion Pharmaceuticals-a
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q3 and 2024-Q4. According to the most recent SEC 13F filing, 26 superinvestors own shares of Recursion Pharmaceuticals-a (RXRX), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Recursion Pharmaceuticals-a (RXRX), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Recursion Pharmaceuticals-a (RXRX) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Recursion Pharmaceuticals-a (RXRX) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Kevin Hixson@Financial Management Professionals, Inc.
| 0.01% | $5,678 840 shares@ 6.76 avg price | |
Erkko Etula@Brooklyn Investment Group
| 0.01% | $4,895 724 shares@ 6.77 avg price | New Position |
Colleen Doughty@Roble, Belko & Company, Inc
| 0.01% | $1,000 141 shares@ 7.1 avg price | Increased 781.25% |
Ryan Jacobs@Albion Financial Group Ut
| 0.01% | $812 120 shares@ 6.77 avg price | |
Mark Mowrey@Signature Resources Capital Management, Llc
| 0.01% | $257 38 shares@ 6.77 avg price | New Position |
Dominic DiGiacomo@Cranbrook Wealth Management, Llc
| 0.01% | $237 35 shares@ 6.78 avg price |